ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Clinical trial NCT06360289 updates: 1. completion date: 2027-12-01 → 2027-12-15 2. primary completion date: 2027-12-01 → 2027-12-15
Clinical trial NCT06360289 updates: 1. completion date: 2027-12-01 → 2027-12-15 2. primary completion date: 2027-12-01 → 2027-12-15
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical